Case Report and Literature Review of Severe Anemia Secondary to Chemotherapy 
Combined with PD-1 Monoclonal Antibody Immunotherapy for Lung Adenocarcinoma

Case Report and Literature Review of Severe Anemia Secondary to Chemotherapy 
Combined with PD-1 Monoclonal Antibody Immunotherapy for Lung Adenocarcinoma

Programmed cell death 1 (PD-1) inhibitor therapy for lung adenocarcinoma may induce rare but severe hematologic adverse events, including severe anemia. Although glucocorticoids are recommended for managing immune-related adverse events, therapeutic experience with PD-1 inhibitor-induced severe anem...

Full description

Saved in:
Bibliographic Details
Main Authors: Yaowen HU, Jing ZHAO, Xiaoxing GAO, Yan XU, Mengzhao WANG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2025-06-01
Series:Chinese Journal of Lung Cancer
Subjects:
lung neoplasms
immune checkpoint inhibitors
programmed cell death 1
immune-related adverse events
anemia
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2025.102.25
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items